Episode 102: Building Patient-Centered Biotech Deals for a Stronger Future in Healthcare
How can healthcare investment banking put patients—not just profits—at the center of biotech deals?
In this episode, host James Zanewicz, JD, LLM, RTTP, speaks with Sam Libby, President and Managing Director of TCB Capital Advisors. Drawing from more than $20 billion in transactions across therapeutics, diagnostics, and digital health, Sam explains how TCB’s unique advisory model partners with companies before and after deals close. From growing up with therapist parents to founding a merchant bank, Sam shares how personal values and professional experience can come together to shape smarter strategies for healthcare innovation.
In this episode, you’ll learn:
- Why patient-centered thinking belongs at the core of investment strategy.
- Common mistakes healthcare startups make when pitching to investors—and how to avoid them.
- The critical role of clinical data, mission alignment, and timing in building sustainable biotech companies.
Tune in to learn how to navigate healthcare investments with purpose and ensure your biotech mission makes a lasting impact.
Links:
Connect with Sam Libby, and check out TCB Capital Advisors.
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about Clairity and Informuta.
Listen to our previous episode on Drug Pricing and Accessibility.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
